This group began as the Methods Validation team of Innovation to Impact (I2I), an LSTM-hosted programme funded by the Gates Foundation that worked from 2015 to 2025 to address underlying barriers to innovation and quality management in vector control. When I2I closed in April 2025, its focus areas were handed over to associated groups to take forward; the Methods Validation work continues here.
Between 2021 and 2025, the team critically reviewed bioassays and related methods used in the development and evaluation of vector control tools. The aim was to identify and minimise sources of variability, and to find gaps in knowledge of how best to test existing and new tools. The team addressed these gaps by developing consensus protocols, experimentally validating existing and new methods, and working with stakeholders to identify concerns and generate solutions, including best-practice protocols and data analysis tools.